![](/img/cover-not-exists.png)
Cost Effectiveness of Pembrolizumab (Keytruda®) Versus Ipilimumab in Patients with Advanced Melanoma in the United States
Wang, J, Pellissier, J, Xu, R, Liu, FX, Stevinson, K, Chmielowski, BVolume:
19
Language:
english
Journal:
Value in Health
DOI:
10.1016/j.jval.2016.03.1613
Date:
May, 2016
File:
PDF, 63 KB
english, 2016